Basic Information
ID: ALA4837924
Type: Functional
Description: Antiviral activity against HIV1 Env-deficient VSV-G pseudotyped virus infected in human SUP-T1 cells infected with supernatant of compound treated virus-producing 293T cells assessed as inhibition of late stage viral production at 10 uM treated for 48 hrs with virus-producing 293T cells followed by SUP-T1 cells infection for 48 hrs by single-round infection luciferase assay relative to control
Format: BAO_0000218
Organism: Human immunodeficiency virus 1
Cell type: SUP-T1
Target: Human immunodeficiency virus 1(ALA378)
Document: ALA4837199
Antiviral activity against HIV1 Env-deficient VSV-G pseudotyped virus infected in human SUP-T1 cells infected with supernatant of compound treated virus-producing 293T cells assessed as inhibition of late stage viral production at 10 uM treated for 48 hrs with virus-producing 293T cells followed by SUP-T1 cells infection for 48 hrs by single-round infection luciferase assay relative to control: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4837924
Inhibition
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 502.68 | 2.00 | 2.00 |
| 517.69 | 2.57 | 2.57 |
| 569.69 | 3.78 | 3.78 |
| 531.72 | 2.77 | 2.77 |
| 516.71 | 2.35 | 2.35 |
| 532.71 | 2.61 | 2.61 |
| 547.72 | 3.04 | 3.04 |
| 517.69 | 2.43 | 2.43 |
| 517.69 | 2.43 | 2.43 |